Condition: Uncomplicated Plasmodium Falciparum Malaria · Sponsor: Novartis Pharmaceuticals
Platform study to evaluate the efficacy and safety of anti-malarial agents in patients with uncomplicated Plasmodium falciparum malaria
This description comes directly from the study's public registry record.
Novartis Pharmaceuticals · +41613241111 · novartis.email@novartis.com
Novartis Pharmaceuticals
Always discuss trial participation with your own doctor first.
| Novartis Investigative Site | Banfora, Burkina Faso | Recruiting |
| Novartis Investigative Site | Nanoro, Burkina Faso | Recruiting |
| Novartis Investigative Site | Abidjan, Côte d’Ivoire | Recruiting |
| Novartis Investigative Site | Azaguié, Côte d’Ivoire | Recruiting |
| Novartis Investigative Site | Lambaréné, Gabon | Recruiting |
| Novartis Investigative Site | Libreville, Gabon | Recruiting |
| Novartis Investigative Site | Kintampo, Ghana | Recruiting |
| Novartis Investigative Site | Navrango, Ghana | Recruiting |
| Novartis Investigative Site | Ahero, Kisumu County, Kenya | Recruiting |
| Novartis Investigative Site | Kisumu, Kenya | Recruiting |
| Novartis Investigative Site | Kampala, Uganda | Recruiting |
| Novartis Investigative Site | Tororo, Uganda | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05750628